leo: extract claims from 2026-04-22-csr-biosecurity-ai-action-plan-review

- Source: inbox/queue/2026-04-22-csr-biosecurity-ai-action-plan-review.md
- Domain: grand-strategy
- Claims: 0, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Leo <PIPELINE>

domains/grand-strategy/anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities.md

@@ -30,3 +30,10 @@ The AI Action Plan's authorship and enforcement architecture confirms the decoup
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR documents that the AI Action Plan calls for mandatory nucleic acid synthesis screening for federally funded institutions while not replacing DURC/PEPP institutional review. This represents a category substitution: input screening (nucleic acid synthesis) replaces research decision oversight (institutional review), addressing a different layer of the biosecurity problem. The plan reinforces CAISI's role in evaluating frontier AI systems for bio risks, shifting governance authority from science agencies to national security apparatus.
+
+
+## Extending Evidence
+
+**Source:** Council on Strategic Risks, AI Action Plan review, July 2025
+
+CSR's review reveals the AI Action Plan reinforces CAISI's role in evaluating frontier AI systems for national security risks including bio risks, while not restoring the institutional biosecurity review framework. This confirms the structural decoupling operates at the policy implementation level—AI-bio compound risk is acknowledged and assigned to national security apparatus (CAISI) rather than biosecurity governance mechanisms (DURC/PEPP institutional review).

domains/grand-strategy/biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship.md

@@ -23,3 +23,10 @@ The White House AI Action Plan (July 23, 2025) lists three co-authors: OSTP Dire
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR notes the AI Action Plan reinforces CAISI's (Center for AI Security and Innovation) role in evaluating frontier AI systems for national security risks including bio risks. This confirms the authority shift pattern where AI-bio convergence governance moves from science agencies (which administered DURC/PEPP) to national security apparatus (CAISI).
+
+
+## Supporting Evidence
+
+**Source:** Council on Strategic Risks, AI Action Plan review, July 2025
+
+CSR documents that the AI Action Plan assigns AI-bio risk evaluation to CAISI (national security apparatus) while leaving the DURC/PEPP institutional review vacuum unfilled. This confirms the authority shift is not just authorship but operational—biosecurity governance for AI-enabled threats is routed through national security evaluation rather than science agency institutional review.

domains/grand-strategy/durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline.md

@@ -37,3 +37,10 @@ Council on Strategic Risks' July 2025 review of the AI Action Plan confirms the
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 Council on Strategic Risks review of the AI Action Plan (July 2025) confirms the plan explicitly acknowledges AI can provide 'step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal' but does not replace the DURC/PEPP institutional review framework. This is the authoritative biosecurity source documenting that the governance vacuum persists even after the AI Action Plan's release, and that the plan's authors made a deliberate choice to acknowledge the risk without restoring institutional oversight mechanisms.
+
+
+## Extending Evidence
+
+**Source:** Council on Strategic Risks, AI Action Plan review, July 2025
+
+Council on Strategic Risks review of the AI Action Plan (July 2025) confirms the governance vacuum persists: the plan explicitly acknowledges AI can provide 'step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal' but does not replace the DURC/PEPP institutional review framework. This is the authoritative biosecurity source documenting that the AI Action Plan's authors made a deliberate governance architecture choice—acknowledging AI-bio synthesis risk while not restoring institutional oversight mechanisms.

domains/grand-strategy/nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions.md

@@ -10,7 +10,7 @@ agent: leo
 sourced_from: grand-strategy/2026-04-22-cset-georgetown-ai-action-plan-recap.md
 scope: functional
 sourcer: CSET Georgetown
-related: ["durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "anti-gain-of-function-framing-creates-structural-decoupli-between-ai-governance-and-biosecurity-governance-communities", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions"]
+related: ["durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "anti-gain-of-function-framing-creates-structural-decoupli-between-ai-governance-and-biosecurity-governance-communities", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions", "biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship"]
 ---
 
 # Nucleic acid screening cannot substitute for institutional oversight in biosecurity governance because screening filters inputs not research decisions
@@ -30,3 +30,10 @@ CSR's review provides authoritative biosecurity community confirmation of the ca
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR's review provides the third independent source (alongside CSET and RAND) confirming the AI Action Plan's category substitution pattern. The plan mandates nucleic acid synthesis screening while leaving the DURC/PEPP institutional review vacuum unfilled, despite explicitly acknowledging AI-enabled pathogen synthesis risk. This is the credibility anchor from the most authoritative biosecurity voice.
+
+
+## Supporting Evidence
+
+**Source:** Council on Strategic Risks, AI Action Plan review, July 2025
+
+The AI Action Plan calls for mandatory nucleic acid synthesis screening for federally funded institutions while not replacing DURC/PEPP institutional review. CSR's contemporaneous review documents this as a category substitution—the plan addresses input filtering (screening nucleic acid orders) rather than research decision governance (institutional review of dual-use research). This confirms the substitution pattern with the most credible biosecurity specialist source.